X
Edition:
United States

  • Business
    • Business Home
    • Legal
    • Deals
    • Aerospace & Defense
    • Finance
    • Autos
    • Reuters Summits
    • ADventures
    • Data Dive
  • Markets
    • Markets Home
    • U.S. Markets
    • European Markets
    • Asian Markets
    • Global Market Data
    • Indices
    • Stocks
    • Bonds
    • Currencies
    • Commodities
    • Futures
    • Funds
    • Earnings
    • Dividends
  • World
    • World Home
    • U.S.
    • Special Reports
    • Reuters Investigates
    • Euro Zone
    • Middle East
    • China
    • Japan
    • Mexico
    • Brazil
    • Africa
    • Russia
    • India
  • Politics
    • Politics Home
    • Polling Explorer
    • Live: Trump's First 100 Days
    • What Voters Want
    • Supreme Court
  • Tech
    • Technology Home
    • Science
    • Top 100 Global Innovators
    • Media
    • Environment
    • Innovation
  • Commentary
    • Commentary Home
    • Podcasts
  • Breakingviews
    • Breakingviews Home
    • Breakingviews Video
  • Money
    • Money Home
    • Retirement
    • Lipper Awards
    • Analyst Research
    • Stock Screener
    • Fund Screener
  • Life
    • Health
    • Sports
    • Arts
    • Entertainment
    • Oddly Enough
  • Pictures
    • Pictures Home
    • The Wider Image
    • Photographers
    • Focus 360
  • Video
Swiss drug policy should serve as model: experts
  • Africa
    América Latina
  • عربي
    Argentina
  • Brasil
    Canada
  • 中国
    Deutschland
  • España
    France
  • India
    Italia
  • 日本
    México
  • РОССИЯ
    United Kingdom
  • United States
Health News | Mon Oct 25, 2010 | 1:02pm EDT

Swiss drug policy should serve as model: experts

By Stephanie Nebehay | GENEVA

GENEVA Switzerland's innovative policy of providing drug addicts with free methadone and clean needles has greatly reduced deaths while cutting crime rates and should serve as a global model, health experts said on Monday.

Countries whose drug policy remains focused on punishing offenders, including Russia and much of Eastern Europe and Central Asia, should learn from a Swiss strategy based on "harm reduction" that protects both users and communities, they said.

Even Iran and China -- while far from espousing Switzerland's system of direct democracy -- have copied its methadone substitution programs, they added.

The Alpine nation's experiment succeeded because Swiss political leaders adopted a pragmatic attitude toward an "uncontrollable" open drugs scene, according to a report "From the Mountaintops: What the World Can Learn from Drug Policy Change in Switzerland," by the Open Society Foundations.

Soaring HIV infection rates, the highest in Western Europe, sparked alarm among the conservative public in the late 1980s and early 1990s, when up to 1,000 drug users gathered daily in Zurich's infamous Platzspitz park, dubbed "needle park."

"We had to change perspective and introduce the notion of public health. We extended a friendly hand to drug addicts and brought them out of the shadows," Ruth Dreifuss, a former Swiss president and interior minister (1993-2002), told a briefing.

Swiss authorities authorized experiments such as syringe exchange programs and safe injection rooms offering a shower, bed and hygienic conditions under medical supervision, said Dreifuss, who led the campaign to reform narcotic drug policy.

HIV, DEATH RATES SLASHED

Some 70 percent of the 20,000-30,000 opiate or cocaine users in Switzerland now receive treatment, one of the highest rates globally, said Dr. Ambros Uchtenhagen, who helped pioneer heroin substitution and chairs the Research Institute for Public Health and Addiction at Zurich University.

"The number of drug injectors with HIV has been reduced by over 50 percent in 10 years. Overdose mortality among injectors has been reduced by over 50 percent in the decade," he said. "Delinquency related to drugs has been reduced enormously."

Family doctors now prescribe about 60 percent of opiate substitution treatment in Switzerland and the Internet was vital in informing users about access to treatment, Uchtenhagen added.

"I'm really impressed with the policies Switzerland has put in place, which are based on sound science and grounded in good global health policies and human rights," said Dr. Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, TB and Malaria. "Switzerland is clearly a pioneer."

Up to 10 percent of all new HIV infections worldwide every year occur through injecting drug use, he said. An estimated 3 million of the 33.4 million people living with the HIV virus inject drugs, he said. "So it is a huge problem."

The AIDS epidemic is spreading faster in the Eastern Europe and Central Asia region than anywhere else, led by drug users, according to Kazatchkine. "We are still facing huge societal, political and cultural resistance to implementing evidence-based policies for intravenous drug uses," he said.

He said Russia, home to nearly 1 million people living with HIV, more than half of them drug-users, was especially reluctant to abandon its drugs policy based on law and order.

"Russia is totally closed to the idea, it is impossible to open a dialogue," Kazatchkine said.

Next In Health News

Bird flu hits poultry markets in major Chinese city: media

BEIJING Authorities in China's third-largest city warned that about 30 percent of its live poultry markets were contaminated with the H7N9 avian flu virus, as an eastern province ordered markets to shut, state media reported on Saturday.

Venezuelan girl's diphtheria death highlights country's health crisis

PARIAGUAN, Venezuela Eliannys Vivas, 9, started to get a sore throat on a Friday last month in this languid Venezuelan town where papaya trees shade poor cinder-block homes.

Bolivia reports first yellow fever case in a decade

LA PAZ Bolivia's government on Friday said a Danish tourist had tested positive for yellow fever, its first case in a decade, after he visited a jungle area in the far west of the landlocked Andean country.

MORE FROM REUTERS

Sponsored Content

From Around the WebPromoted by Revcontent

Trending Stories

    Pictures

    Photos of the week

    Sponsored Topics

    X
    Follow Reuters:
    • Follow Us On Twitter
    • Follow Us On Facebook
    • Follow Us On RSS
    • Follow Us On Instagram
    • Follow Us On YouTube
    • Follow Us On LinkedIn
    Subscribe: Feeds | Newsletters | Podcasts | Apps
    Reuters News Agency | Brand Attribution Guidelines | Careers

    Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

    Eikon
    Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface
    Elektron
    Everything you need to empower your workflow and enhance your enterprise data management
    World-Check
    Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks
    Westlaw
    Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology
    ONESOURCE
    The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
    CHECKPOINT
    The industry leader for online information for tax, accounting and finance professionals

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    • Site Feedback
    • Corrections
    • Advertising Guidelines
    • Cookies
    • Terms of Use
    • Privacy Policy